Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
Acta Pharmaceutica Sinica B · 2023-04 · 13 (4) · 1429-1437
DOI: 10.1016/j.apsb.2022.07.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-04. Verfasst von Kamila Butowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Narodowa Agencja Wymiany Akademickiej, American Cancer Society, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Intercollegiate Faculty of Biotechnology, University of Gdańsk & Medical University of Gdańsk, Gdańsk 80-307, Poland.
- Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Bioengineering, Temple University, Philadelphia, PA 19122, USA.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Förderung
- Narodowa Agencja Wymiany Akademickiej
- American Cancer Society
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- Burroughs Wellcome Fund
- Canadian Aeronautics and Space Institute
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Butowska, K., Han, X., Gong, N., El-Mayta, R., Haley, R. M., Xue, L., Zhong, W., Guo, W., Wang, K., & Mitchell, M. J. (2023). Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy. Acta Pharmaceutica Sinica B, 13(4), 1429-1437. https://doi.org/10.1016/j.apsb.2022.07.011
Vancouver
Butowska K, Han X, Gong N, El-Mayta R, Haley RM, Xue L, et al. Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy. Acta Pharmaceutica Sinica B. 2023;13(4):1429-1437. doi:10.1016/j.apsb.2022.07.011
BibTeX
@article{Butowska2023,
author = {Butowska, Kamila and Han, Xuexiang and Gong, Ningqiang and El-Mayta, Rakan and Haley, Rebecca M and Xue, Lulu and Zhong, Wenqun and Guo, Wei and Wang, Karin and Mitchell, Michael J},
title = {Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {4},
pages = {1429--1437},
doi = {10.1016/j.apsb.2022.07.011}
}
EUVIMED